91
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Neuronal affinity of a C7C loop peptide identified through phage display

, , , , &
Pages 263-271 | Published online: 08 Oct 2008

References

  • Adda CG, Anders RF, Tilley L, Foley M. Random sequence libraries displayed on phage: Identification of biologically important molecules. Comb Chem High Throughput Screen 2002; 5: 1–14
  • Barry MA, Dower WJ, Johnston SA. Toward cell-targeting gene therapy vectors: Selection of cell-binding peptides from random peptide-presenting phage libraries. Nat Med 1996; 2: 299–305
  • Benitez JA, Segovia J. Gene therapy targeting in the central nervous system. Curr Gene Ther 2003; 3: 127–145
  • Boulis NM, Noordmans AJ, Song DK, Imperiale MJ, Rubin A, Leone P, During M, Feldman EL. Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery. Neurobiol Dis 2003; 14: 535–541
  • Buning H, Ried MU, Perabo L, Gerner FM, Huttner NA, Enssle J, Hallek M. Receptor targeting of adeno-associated virus vectors. Gene Ther 2003; 10: 1142–1151
  • Burger C, Gorbatyuk OS, Velardo MJ, Peden CS, Williams P, Zolotukhin S, Reier PJ, Mandel RJ, Muzyczka N. Recombinant aav viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther 2004; 10: 302–317
  • Davis A, Stachler M, Shi W, Liu J, Boulis N, Bartlett J. Manipulating aav2 tropism for enhanced delivery of aav vectors to the spinal cord. Mol Ther 2005; 11: S46
  • Engelstadter M, Bobkova M, Baier M, Stitz J, Holtkamp N, Chu TH, Kurth R, Dornburg R, Buchholz CJ, Cichutek K. Targeting human t cells by retroviral vectors displaying antibody domains selected from a phage display library. Hum Gene Ther 2000; 11: 293–303
  • Federici T, Liu J, Teng Q, Garrity-Moses M, Yang J, Boulis N. In vivo spinal cord uptake and neuronal binding properties of tet1: A potential means for enhanced spinal cord aav delivery. Mol Ther 2005; 11: S332
  • Fishman PS, Parks DA, Patwardhan AJ, Matthews CC. Neuronal binding of tetanus toxin compared to its ganglioside binding fragment (h(c)). Nat Toxins 1999; 7: 151–156
  • Giebel LB, Cass RT, Milligan DL, Young DC, Arze R, Johnson CR. Screening of cyclic peptide phage libraries identifies ligands that bind streptavidin with high affinities. Biochemistry 1995; 34: 15430–15435
  • Girod A, Ried M, Wobus C, Lahm H, Leike K, Kleinschmidt J, Deleage G, Hallek M. Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2. Nat Med 1999; 5: 1052–1057
  • Grifman M, Trepel M, Speece P, Gilbert LB, Arap W, Pasqualini R, Weitzman MD. Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids. Mol Ther 2001; 3: 964–975
  • Hallenbeck PL, Stevenson SC. Targetable gene delivery vectors. Adv Exp Med Biol 2000; 465: 37–46
  • Herreros J, Lalli G, Montecucco C, Schiavo G. Tetanus toxin fragment c binds to a protein present in neuronal cell lines and motoneurons. J Neurochem 2000; 74: 1941–1950
  • Ho KL, Yusoff K, Seow HF, Tan WS. Selection of high affinity ligands to hepatitis b core antigen from a phage-displayed cyclic peptide library. J Med Virol 2003; 69: 27–32
  • Hou S, Dove M, Anderson E, Zhang J, MacKenzie C. Identification of polypeptides with selective affinity to intact mouse cerebellar granule neurons from a random peptide-presenting phage library. J Neurosci Methods 2004; 138: 39–44
  • Jost PJ, Harbottle RP, Knight A, Miller AD, Coutelle C, Schneider H. A novel peptide, thalwht, for the targeting of human airway epithelia. FEBS Lett 2001; 489: 263–269
  • Kaspar BK, Llado J, Sherkat N, Rothstein JD, Gage FH. Retrograde viral delivery of igf-1 prolongs survival in a mouse als model. Science 2003; 301: 839–842
  • Koivunen E, Wang B, Ruoslahti E. Isolation of a highly specific ligand for the alpha 5 beta 1 integrin from a phage display library. J Cell Biol 1994; 124: 373–380
  • Larocca D, Burg MA, Jensen-Pergakes K, Ravey EP, Gonzalez AM, Baird A. Evolving phage vectors for cell targeted gene delivery. Curr Pharm Biotechnol 2002; 3: 45–57
  • Lieber A, Muller OJ, Kaul F, Weitzman MD, Pasqualini R, Arap W, Kleinschmidt JA, Trepel M. Aav display-homing in on the target random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors. Nat Biotechnol 2003; 21: 1011–1013
  • Liu JK, Teng Q, Garrity-Moses M, Federici T, Tanase D, Imperiale MJ, Boulis NM. A novel peptide defined through phage display for therapeutic protein and vector neuronal targeting. Neurobiol Dis 2005; 19: 407–418
  • Muller OJ, Kaul F, Weitzman MD, Pasqualini R, Arap W, Kleinschmidt JA, Trepel M. Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors. Nat Biotechnol 2003; 21: 1040–1046
  • Nathan A, Yavin E. Periodate-modified gangliosides enhance surface binding of tetanus toxin to pc12 pheochromocytoma cells. J Neurochem 1989; 53: 88–94
  • Nicklin SA, Von Seggern DJ, Work LM, Pek DC, Dominiczak AF, Nemerow GR, Baker AH. Ablating adenovirus type 5 fiber-car binding and hi loop insertion of the sigyplp peptide generate an endothelial cell-selective adenovirus. Mol Ther 2001; 4: 534–542
  • Perabo L, Buning H, Kofler DM, Ried MU, Girod A, Wendtner CM, Enssle J, Hallek M. In vitro selection of viral vectors with modified tropism: The adeno-associated virus display. Mol Ther 2003; 8: 151–157
  • Romanczuk H, Galer CE, Zabner J, Barsomian G, Wadsworth SC, O'Riordan CR. Modification of an adenoviral vector with biologically selected peptides: A novel strategy for gene delivery to cells of choice. Hum Gene Ther 1999; 10: 2615–2626
  • Samoylova T, Ahmed B, Vodyanoy V, Morrison N, Samoylov A, Globa L, Baker H, Cox N. Targeting peptides for microglia identified via phage display. J Neuroimmunol 2002; 127: 13–21
  • Shevtsova Z, Malik JM, Michel U, Bahr M, Kugler S. Promoters and serotypes: Targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo. Exp Physiol 2005; 90: 53–59
  • Shi W, Bartlett J. Rgd inclusion in vp3 provides adeno-associated virus type 2 (aav2)-based vectors with a heparan sulfate-independent cell entry mechanism. Mol Ther 2003; 7: 515–525
  • Shi W, Arnold GS, Bartlett JS. Insertional mutagenesis of the adeno-associated virus type 2 (aav2) capsid gene and generation of aav2 vectors targeted to alternative cell-surface receptors. Hum Gene Ther 2001; 12: 1697–1711
  • Trepel M, Grifman M, Weitzman MD, Pasqualini R. Molecular adaptors for vascular-targeted adenoviral gene delivery. Hum Gene Ther 2000; 11: 1971–1981
  • Wang LF, Yu M. Epitope identification and discovery using phage display libraries: Applications in vaccine development and diagnostics. Curr Drug Targets 2004; 5: 1–15
  • Warrington KH, Jr., Gorbatyuk OS, Harrison JK, Opie SR, Zolotukhin S, Muzyczka N. Adeno-associated virus type 2 vp2 capsid protein is nonessential and can tolerate large peptide insertions at its n terminus. J Virol 2004; 78: 6595–6609
  • White SJ, Nicklin SA, Buning H, Brosnan MJ, Leike K, Papadakis ED, Hallek M, Baker AH. Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors. Circulation 2004; 109: 513–519
  • Williamson LC, Bateman KE, Clifford JC, Neale EA. Neuronal sensitivity to tetanus toxin requires gangliosides. J Biol Chem 1999; 274: 25173–25180
  • Wong LF, Azzouz M, Walmsley LE, Askham Z, Wilkes FJ, Mitrophanous KA, Kingsman SM, Mazarakis ND. Transduction patterns of pseudotyped lentiviral vectors in the nervous system. Mol Ther 2004; 9: 101–111
  • Work LM, Nicklin SA, White SJ, Baker AH. Use of phage display to identify novel peptides for targeted gene therapy. Methods Enzymol 2002; 346: 157–176
  • Work LM, Nicklin SA, Brain NJ, Dishart KL, Von Seggern DJ, Hallek M, Buning H, Baker AH. Development of efficient viral vectors selective for vascular smooth muscle cells. Mol Ther 2004; 9: 198–208
  • Writer MJ, Marshall B, Pilkington-Miksa MA, Barker SE, Jacobsen M, Kritz A, Bell PC, Lester DH, Tabor AB, Hailes HC, Klein N, Hart SL. Targeted gene delivery to human airway epithelial cells with synthetic vectors incorporating novel targeting peptides selected by phage display. J Drug Target 2004; 12: 185–193
  • Wu P, Xiao W, Conlon T, Hughes J, Agbandje-McKenna M, Ferkol T, Flotte T, Muzyczka N. Mutational analysis of the adeno-associated virus type 2 (aav2) capsid gene and construction of aav2 vectors with altered tropism. J Virol 2000; 74: 8635–8647
  • Zhang J, Spring H, Schwab M. Neuroblastoma tumor cell-binding peptides identified through random peptide phage display. Cancer Lett 2001; 171: 153–164

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.